Philippines at a glance
- Population
- 116.8 million 2025
- Life expectancy at birth
- 69.9 years, 2024
- People aged 65 and over
- 5.7 % of people, 2025
- Health spending per person
- 194 US$ per person, 2023
- Doctors
- 0.79 per 1,000 people, 2021
Updated
Reviewed by Vidhi Upadhyay
Philippines Colorectal Cancer Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$16.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $17.3 Mn | — | — |
| 2025 (base) | $18.5 Mn | +$1.3 Mn | — |
| 2026 (forecast) | $19.9 Mn | +$1.4 Mn | +7.3% |
| 2027 (forecast) | $21.3 Mn | +$1.5 Mn | +15.1% |
| 2028 (forecast) | $22.9 Mn | +$1.6 Mn | +23.5% |
| 2029 (forecast) | $24.6 Mn | +$1.7 Mn | +32.6% |
| 2030 (forecast) | $26.4 Mn | +$1.8 Mn | +42.2% |
| 2031 (forecast) | $28.3 Mn | +$1.9 Mn | +52.6% |
| 2032 (forecast) | $30.4 Mn | +$2.1 Mn | +63.8% |
| 2033 (forecast) | $32.6 Mn | +$2.2 Mn | +75.7% |
| 2034 (forecast) | $34.9 Mn | +$2.4 Mn | +88.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $18.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $34.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, setting and end user (see all) |
| Key players | Exact Sciences Corporation, Guardant Health, Inc., Olympus Corporation, Quidel Corporation, Eiken Chemical and 1 more (see all) |
| Regulator in the Philippines | FDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Colorectal cancer screening finds bowel cancer and pre-cancer early, using stool tests, blood tests and colonoscopy.
Key segments of the colorectal Cancer Screening market include test (Stool DNA Tests, FIT Tests and Blood-Based Tests) and setting (At-Home, Clinics and Hospitals).
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the colorectal Cancer Screening market. Faster approvals and new combinations are improving survival.
Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the colorectal Cancer Screening market.
High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the colorectal Cancer Screening market, especially in low- and middle-income countries.
The colorectal Cancer Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.[2]
[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[2] PhilHealth. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how colorectal Cancer Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the Philippines.
What doctors and scientists are doing in Colorectal Cancer Screening right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.
From our blog
Philippines · 2 shared keywords
Philippines · 2 shared keywords
Philippines · 2 shared keywords
Philippines · 2 shared keywords
Philippines · 2 shared keywords
Philippines · 2 shared keywords
Digital Health · Philippines
Healthcare Services · Philippines
Pharmaceuticals · Philippines
Pharmaceuticals · Philippines
Healthcare Services · Philippines
Pharmaceuticals · Philippines